|Publication number||US4776849 A|
|Application number||US 07/037,514|
|Publication date||Oct 11, 1988|
|Filing date||Apr 13, 1987|
|Priority date||Nov 6, 1984|
|Publication number||037514, 07037514, US 4776849 A, US 4776849A, US-A-4776849, US4776849 A, US4776849A|
|Inventors||Kouji Shinno, Hitoshi Kuboki|
|Original Assignee||Terumo Kabushiki Kaisha|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (3), Referenced by (32), Classifications (10), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation, of application Ser. No. 792,834, filed Oct. 30, 1985 now aband.
This invention relates to a medical instrument comprising mutually bonded tubular members of flexible resin.
In general, most medical instruments include a plurality of parts of soft or flexible material which are bonded to one another. One such example is a winged venous infusion needle assembly. A needle is secured in a hub or connector of flexible polyvinyl chloride resin which is, in turn, bonded or connected to a tube of flexible polyvinyl chloride resin with an adhesive of the solvent type using, for example, tetrahydrofuran (THF) and methyl ethyl ketone (MEK). The use of solvent-type adhesive, however, gives rise to a number of problems. (1) Solvent attacks parts to be bonded which become brittle or weak and will eventually be broken. (2) Some material is dissolved from parts by solvent and will undesirably block a flowpath. (3) Residual solvent leaves the risk of toxicity. Medical instruments having parts bonded with such solvent-type adhesive suffer from these and other problems. There is the need for a technique capable of bonding parts without using an organic solvent.
It is, therefore, an object of the present invention to provide a novel and improved medical instrument comprising flexible material parts bonded with an increased bond strength without using a conventional organic solvent-containing adhesive.
According to the present invention which attains the above object, there is provided a medical instrument comprising:
a first tubular member of a flexible resin having a Shore D hardness of not higher than 45, and
a second tubular member of a flexible resin having a Shore D hardness of not higher than 45, mated over the first tubular member, characterized in that
the mating portions of the first and second tubular members are bonded with a curable adhesive which shows a Shore D hardness of not higher than 70 after curing.
The shore D hardness used herein is as defined by ASTM D 2240.
In one preferred embodiment, the first tubular member includes a male mating wall provided with at least circumferential groove where the curable adhesive is accommodated. Correspondingly, the second tubular member includes a female mating wall. The male wall of the first tubular member is inserted or engaged in the female wall of the second member.
Preferably, the curable adhesive is of the ultraviolet radiation curable type.
The above and other objects, features, and advantages of the present invention will be better understood by reading the following description taken in conjunction with the accompanying drawings, in which:
FIG. 1 is a plan view of a typical winged infusion needle assembly to which the present invention is applied; and
FIGS. 2 and 3 are partially cross sectional elevations of different embodiments of the medical instrument of the present invention, particularly illustrating the engagement between two parts.
The present invention provides a medical instrument comprising at least two flexible tubular members engaged with one another. The engagement between the members is bonded with a curable adhesive exhibiting a hardness compatible with the hardness of the members. In the present disclosure, that tubular member which comes inside the engagement is referred to as a first tubular member and that tubular member which comes outside the engagement is referred to as a second tubular member.
The medical instruments to which the present invention is applicable are blood and fluid transfusion sets, dialysis circuits, and winged venous infusion needle assemblies, but not limited thereto as long as they have at least one engagement between members.
The medical instrument of the present invention is described with reference to the drawings. Although the bonding of a hub or connector with a tube as used in a winged infusion needle assembly is described as preferred embodiments of the present invention, it should, of course, be understood that that present invention is not limited to these illustrated embodiments. The basic concept of the present invention is to use a curable adhesive instead of a conventional, commonly used solvent-type adhesive. The term curable adhesive used herein means that the adhesive will cure after the lapse of a predetermined time from its application to any member. Some illustrative, nonlimiting examples of the curable adhesives include ultraviolet (UV) curable adhesives, cyanoacrylate instant adhesives, epoxy resin base adhesives, hot melt adhesives, and acrylic adhesives.
FIG. 1 shows an overall winged venous infusion needle assembly as a typical example of the medical instrument to which the present invention is applicable. The present invention is not limited to the winged infusion needle assembly, but is applicable to any medical instrument.
FIG. 2 is an enlarged view of a wing-supporting hub portion of the assembly. More specifically, the embodiment shown in FIG. 2 illustrates the engagement or bonding of a winged hub 1 and a tube 4 of the winged infusion needle assembly. In this embodiment, the hub 1 is the first tubular member and the tube 4 is the second tubular member. The hub 1 has a pair of oppositely extending wings (partially shown) and a bore in which the base of a needle 6 is fixedly secured. The hub 1 includes a tubular male portion extending opposite to the needle 6. The male portion is preferably formed with at least one, preferably a plurality of circumferential or spiral grooves or ribs 5. One end of the tube 4 constitutes a female portion into which the hub male portion is inserted and engaged.
FIG. 3 illustrates another embodiment of the winged infusion needle assembly. More specifically, this embodiment illustrates the engagement or bonding of a connector 2 and a tube 4 of the winged infusion needle assembly. In this embodiment, the tube 4 is the first tubular member and the connector 2 is the second tubular member. One end of the tube 4 constitutes a male portion while one end of the connector 2 constitutes a female portion. The tube male portion is inserted in and engaged with the connector female portion.
In these embodiments, each of hub 1, connector 2, and tube 4 is formed of a flexible resin material having a Shore D hardness of 45 or lower. Resin materials having a Shore D hardness of higher than 45 fail to achieve an critical improvement in bond strength irrespective of a proper choice of the hardness of adhesive as will be described hereinafter. Examples of the resin materials have a Shore D hardness of 45 or higher include flexible polyvinyl chloride (PVC), vinyl chloride elastomers, and styrene elastomers. The hub or connector and the tube to be joined may be formed of the same or different materials as will become apparent from the experimental data.
The hub 1 or connector 2 and the tube 4 both of materials having such a specific hardness are bonded with a curable adhesive 3. Particularly, the mating male and female portions are bonded with the adhesive.
The curable adhesives used herein should show a Shore D hardness of 70 or lower after they have been cured. The use of such adhesives produces at least 20% increase in bond strength as compared with the use of adhesives which provide a Shore D hardness of higher than 70 after curing. No significant bond strength is achievable when the members to be joined and/or the cured adhesive does not meet the above-defined hardness requirements.
Most preferred, but nonlimiting examples of the curable adhesives used herein are UV curable adhesives including polyester acrylate, epoxy acrylate, and polyurethane acrylate types. The term UV curable adhesive used herein means that it cures or hardens upon exposure to electromagnetic radiation of ultrashort wave such as ultraviolet rays and γ-rays.
Referring to FIG. 2 again, the mating portion of the hub 1 or first tubular member in one preferred embodiment is formed with several circumferential grooves or ribs 5 where the curable adhesive 3 accommodates. The instrument may be assembled by applying the adhesive to the ribbed surface of the hub mating portion and then inserting the adhesive-coated portion of the hub into the mating portion of the tube 4 or the second tubular member. It is desirable for the mating portion of the hub 1 to have an outer diameter slightly larger than the inner diameter of the tube 4. After insertion, the hub-tube engagement is exposed for curing to any desired curing factor such as UV radiation, γ-rays, and heat depending on the particular type of adhesive used. It will be understood that the grooves or ribs 5 in the male mating portion of the hub 1 also serve to mechanically engage and retain the tube 4.
In the embodiment shown in FIG. 3, in order to provide a configuration capable of accommodating the adhesive, the mating portion of the connector 2 or second tubular member is formed to have an outward flaring inner surface geometry or an inner diameter slightly larger than the outer diameter of the tube 4 or first tubular member. After the tube 4 is inserted into the connector 2, an outwardly flaring space defined between their mating portions is filled with a curable adhesive. The tube-connector engagement is exposed for curing to any desired curing factor such as UV radiation, γ-rays, and heat depending on the particular type of adhesive used.
Since the assemblies or instruments prepared according to the present invention are intended for medical use, they are finally sterilized, for example, by ethylene oxide gas, autoclave, or γ-ray sterilization. When the adhesive used is of UV curable type, γ-ray exposure is effective to carry out curing and sterilization at the same time.
In order to determine the effectiveness of the present invention, we carried out a number of experiments. Some are given below.
The assemblies of hub 1-tube 4 and connector 2-tube 4 as shown in FIGS. 2 and 3 were prepared. The materials used for the respective parts are shown below. (phr: part per hundred parts of resin)
______________________________________Resin No. Material Shore D hardness______________________________________1 Polyvinyl chloride resin + 25 65 phr plasticizer2 Polyvinyl chloride resin + 35 55 phr plasticizer3 Polyvinyl chloride resin + 38 40 phr plasticizer______________________________________
The adhesive used is a group of UV curable polyurethane acrylate adhesives commercially available from Toa Synthetic Chemicals K.K.
______________________________________Adhesive No. (Grade No.) Shore D hardness after curing______________________________________1 (3576K4) 602 (3596) 643 (3564K1) 664 (3564K4) 705 (3603) 736 (3583) 84______________________________________
Using these materials, a set of 5 specimens was prepared for each of assemblies having different material combinations. The specimens were determined for bond strength using an Autograph DCS-100 tensile tester manufactured by Shimazu Mfg. K.K. operating at a pulling speed of 50 mm/min. Five measurements were averaged for each set.
The results are shown in Table 1.
TABLE 1______________________________________Resin No. Adhesive No. Bond strength(Shore D hardness) (Shore D hardness*) kg______________________________________Hub Tube1(25) 1(25) 1(60) 2.81(25) 1(25) 2(64) 2.81(25) 1(25) 3(66) 2.71(25) 1(25) 4(70) 2.51(25) 1(25) 5(73) 2.11(25) 1(25) 6(84) 2.03(38) 2(35) 1(60) 2.83(38) 2(35) 2(64) 2.73(38) 2(35) 3(66) 2.73(38) 2(35) 4(70) 2.73(38) 2(35) 5(73) 2.23(38) 2(35) 6(84) 2.0Connector Tube3(38) 1(25) 1(60) 2.83(38) 1(25) 2(64) 2.83(38) 1(25) 3(66) 2.73(38) 1(25) 4(70) 2.63(38) 1(25) 5(73) 2.13(38) 1(25) 6(84) 2.1______________________________________ *Shore D hardness of cured adhesive is given in parenthesis.
The medical instrument of the present invention has the following benefits.
(1) Since a conventional solvent-type adhesive is not used to bond parts with each other, all of the problems resulting from the solvent are eliminated, for example, deterioration of part material by solvent, blockage of a flowpath by dissolved material, and toxicity of residual solvent.
(2) The cured hardness of the curable adhesive is chosen so as to be compatible with the hardness of first and second tubular members to be joined, insuring a firm bond. A choice of those adhesives having a cured hardness of 70 or lower in Shore D hardness increases the bond strength by at least 20% as seen from Table 1.
(3) The use of a curable adhesive of ultraviolet curable type provides an additional benefit that instrument sterilization and adhesive curing can be effected at the same time by exposure to gamma radiation.
(4) The provision of circumferential grooves on the male portion of the first tubular member ensures an enhanced bond strength.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4439188 *||May 13, 1982||Mar 27, 1984||Baxter Travenol Laboratories, Inc.||Tube connector|
|DE2913676A1 *||Apr 5, 1979||Oct 16, 1980||Henkel Kgaa||Foil laminate prodn. using solvent-free liq. adhesive - contg. polyester and/or polyether having free isocyanate and (meth)acrylate gps.|
|DE3238299A1 *||Oct 15, 1982||Dec 1, 1983||Terumo Corp||Verbindung fuer medizinische instrumente|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4998925 *||May 24, 1988||Mar 12, 1991||Al Sioufi Habib||I. V. connector|
|US5176673 *||Mar 18, 1991||Jan 5, 1993||Piero Marrucchi||Method and device for manipulating and transferring products between confined volumes|
|US5257832 *||May 7, 1992||Nov 2, 1993||The Regents Of The University Of California||Universal tube connector|
|US5380301 *||Jul 10, 1992||Jan 10, 1995||Sherwood Medical Company||Catheter/hub strain relief and method of manufacture thereof|
|US5830401 *||Feb 25, 1994||Nov 3, 1998||Sherwood Medical Company||Method of manufacturing a catheter/hub strain relief|
|US5836619 *||Oct 28, 1994||Nov 17, 1998||Migada, Inc.||Manually-severable coupling device, and medical infusion assembly including same|
|US5961498 *||Dec 17, 1997||Oct 5, 1999||Schneider (Europe) Gmbh||Catheter with two-ply adhesive layer|
|US6074379 *||Mar 6, 1998||Jun 13, 2000||Sherwood Services Ag||Catheter strain relief device|
|US6165166 *||Jan 28, 1998||Dec 26, 2000||Schneider (Usa) Inc.||Trilayer, extruded medical tubing and medical devices incorporating such tubing|
|US6319228||Apr 25, 1997||Nov 20, 2001||Schneider (Europe) A.G.||Multilayer interventional catheter|
|US6464683||Oct 24, 2000||Oct 15, 2002||Schneider (Usa) Inc.||Trilayer, extruded medical tubing and medical devices incorporating such tubbing|
|US6471673||May 24, 1999||Oct 29, 2002||Schneider (Europe) A.G.||Catheter with multilayer tube|
|US6659977||Oct 15, 2001||Dec 9, 2003||Schneider (Europe) A.G.||Multilayer interventional catheter|
|US6960187||Oct 25, 2002||Nov 1, 2005||Schneider Gmbh||Catheter with multilayer tube|
|US7455325 *||Dec 29, 2004||Nov 25, 2008||Unomedical A/S||Connecting element comprising a first body and a method for injection moulding a connecting element|
|US7485108||Oct 29, 2003||Feb 3, 2009||Schneider (Europe) A.G.||Multilayer interventional catheter|
|US7635347||Sep 16, 2005||Dec 22, 2009||Schneider (Europe) A.G.||Catheter with multilayer tube|
|US7815625||Apr 20, 2006||Oct 19, 2010||Boston Scientific Scimed, Inc.||Catheter having improved bonding region|
|US7942849||Dec 16, 2009||May 17, 2011||Schneider Gmbh||Catheter with multilayer tube|
|US8066666||Jan 28, 2009||Nov 29, 2011||Schneider (Europe) A.G.||Multilayer interventional catheter|
|US8216498||Sep 10, 2008||Jul 10, 2012||Boston Scientific Scimed, Inc.||Catheter having a coextruded fluoropolymer layer|
|US8292874||Oct 19, 2010||Oct 23, 2012||Boston Scientific Scimed, Inc.||Catheter having improved bonding region|
|US8636717||Oct 23, 2012||Jan 28, 2014||Boston Scientific Scimed, Inc.||Catheter having improved bonding region|
|US20030088265 *||Oct 25, 2002||May 8, 2003||Schneider (Europe) A.G.||Catheter with multilayer tube|
|US20040092866 *||Oct 29, 2003||May 13, 2004||Schneider (Europe) A.G.||Multilayer interventional catheter|
|US20050142945 *||Dec 29, 2004||Jun 30, 2005||Unomedical A/S||Connecting element comprising a first body and a method for injection moulding a connecting element|
|US20060015064 *||Sep 16, 2005||Jan 19, 2006||Schneider (Europe) A.G.||Catheter with multilayer tube|
|US20090137954 *||Jan 28, 2009||May 28, 2009||Schneider (Europe) Gmbh||Multilayer Interventional Catheter|
|US20100094210 *||Dec 16, 2009||Apr 15, 2010||Schneider (Europe) Ag||Catheter with Multilayer Tube|
|US20110034904 *||Oct 19, 2010||Feb 10, 2011||Boston Scientific Scimed, Inc.||Catheter having improved bonding region|
|WO1994015134A1 *||May 7, 1993||Jul 7, 1994||The Regents Of The University Of California||Universal tube connector|
|WO1995012780A1 *||Oct 28, 1994||May 11, 1995||Migada, Inc.||Manually-severable coupling device, and medical infusion assembly including same|
|U.S. Classification||604/533, 604/905|
|International Classification||A61M39/00, A61M25/00, A61M5/158, A61M39/02, B29C65/54|
|Cooperative Classification||Y10S604/905, A61M25/0014|
|Nov 21, 1989||CC||Certificate of correction|
|Mar 27, 1992||FPAY||Fee payment|
Year of fee payment: 4
|Apr 1, 1996||FPAY||Fee payment|
Year of fee payment: 8
|Apr 3, 2000||FPAY||Fee payment|
Year of fee payment: 12